Skip to main content

ASCIA Action, First Aid, Management, Transfer, Travel and Treatment Plans


ASCIA Action Plans for Anaphylaxis

ASCIA Action Plans for Anaphylaxis are emergency response plans for severe allergic reactions (anaphylaxis). Major updates were made in the 2023 versions, and only minor updates have been made to the 2025 versions. Prior versions (2023) will still be valid for use in 2025.

For further information about ASCIA Action Plans go to www.allergy.org.au/hp/anaphylaxis/action-plans-for-allergic-reactions-faq 

ASCIA Action Plan for Anaphylaxis (RED) 2025

The general version of this plan is for people with allergies who have been prescribed either brand of adrenaline device.

Device specific versions are available below.
These plans are not for allergic rhinitis (hay fever) due to pollen, dust mite, animals or other inhaled allergens.

ASCIA Action Plan for Drug Allergy (GREEN)

ASCIA Action Plan for Drug (Medication) Allergy (GREEN) 2025

This plan is provided to people with drug (medication) allergies who are not usually prescribed an adrenaline device, because accidental exposure to drugs can mostly be avoided.  They are usually recommended to wear medical identification, to avoid exposure to drugs used in medical procedures. 

pdfASCIA Action Plan for Drug Allergy (GREEN) 2025 

ASCIA Record for Drug (Medication) Allergy (GREEN) 2023

This record should be used in conjunction with the patient’s ASCIA Action Plan for Drug (Medication) Allergy

pdfASCIA Record Drug Allergy 2023 

ASCIA Action Plan for Allergic Reactions (GREEN)

ASCIA Action Plan for Allergic Reactions (GREEN) 2025

This plan is provided to people with allergies who have not been prescribed an adrenaline device. 

This plan is not for allergic rhinitis (hay fever) due to pollen, dust mite, animals or other inhaled allergens.

ASCIA First Aid Plans for Anaphylaxis (ORANGE)

This plan can be used as a poster or stored with general use adrenaline devices.

A version of this plan for use by crew on aircraft is available upon request.

For translated versions of the ASCIA First Aid for Anaphylaxis go to www.allergy.org.au/hp/anaphylaxis#ta5

ASCIA First Aid Plan for Anaphylaxis (ORANGE) 2025

The general version of this plan can be used as a poster or stored with either brand of general use adrenaline devices. 

Device specific versions are available below.

ASCIA First Aid Plan for Anaphylaxis (ORANGE) 2025 Pictorial Poster

This plan can be used as a poster or stored with general use adrenaline devices. 

ASCIA Travel Plan for people at risk of anaphylaxis

ASCIA Travel Plan for people at risk of anaphylaxis 2023

This plan should be used with an ASCIA Action Plan for Anaphylaxis.

ASCIA Action Plan and Management Plan for Eczema

ASCIA Action Plan
for Eczema 

pdfASCIA Action Plan for Eczema

ASCIA Stepwise Management
Plan for Eczema

pdfASCIA Stepwise Management Plan for Eczema 2022

ASCIA Action Plan and Management Plan for Eosinophilic Oesophagitis (EoE)

ASCIA Action Plan for EoE
ASCIA Action Plan
for EoE 

pdfASCIA Action Plan for EoE

ASCIA Management Plan for EoE
ASCIA Management Plan
for EoE

pdfASCIA Management Plan EoE

ASCIA Action Plan for FPIES (food protein-induced enterocolitis syndrome) 

ASCIA Action Plan for FPIES
ASCIA Action Plan for FPIES (food protein-induced enterocolitis syndrome) 

pdfASCIA Action Plan FPIES 2023 

ASCIA Management Plan for Delayed Allergic Reactions to Foods
ASCIA Management Plan for Delayed Allergic Reactions to Foods

pdfASCIA Management Plan for Delayed Allergic Reactions to Foods 2023 

ASCIA Immunodeficency Plans 

ASCIA SCIg (subcutaneous immunoglobulin) Treatment Plan

pdfASCIA Treatment Plan SCIG 2024105.65 KB

ASCIA Transfer Care Plan for patients on IRT (immunoglobulin replacement therapy) 

pdfASCIA Treatment Summary Immunoglobulin Therapy 2024118.04 KB

ASCIA Travel Plan for patients on SCIg (subcutaneous immunoglobulin) therapy

pdfASCIA Travel Plan SCIG 2024115.42 KB

ASCIA Management Plan for Hereditary Angioedema (HAE)

 ASCIA Treatment Plan for Allergic Rhinitis

 ASCIA Treatment Plans for Immunotherapy

Content updated August 2024